OSSIO Secures $27.6M to Scale Bio-Integrative Fixation Technology
Slice of Healthcare Team
Dec 10, 2024
Key Highlights
- OSSIO raises $27.6M in equity funding led by Questa Capital to scale operations.
- Focus on new product pipeline, U.S. manufacturing, and surgeon training center in Florida.
- Over 50,000 OSSIOfiber implants used since 2019 across diverse orthopedic procedures.
- OSSIOfiber implants fully integrate with bone, offering a credible alternative to metal.
- Expansion to strengthen U.S. and international sales channels and support surgeon adoption.
Source: Business Wire
Notable Quotes
“ This new investment in OSSIO strengthens our ability to build upon our proven claim as the most innovative and differentiated implant technology to enter the $16 billion orthopedic fixation market. ”
Brian Verrier, CEO at OSSIO
“ OSSIO fits squarely into our investment strategy. The company is growing rapidly and has established OSSIOfiber implants as a differentiated and disruptive medical technology with clear patient benefits and passionate surgeon users. ”
Ryan Drant, Founder and Managing Partner at Questa Capital
